Figure 2:
Cumulative incidence of ACM, HHF and abrupt decline in kidney function and (top to bottom) per 1000 patients treated with placebo versus dapagliflozin, in addition to standard therapy, over a 10-year horizon. ST: standard therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.